ANNOUNCEMENT | |
Date: | 26 November 2021 |
To: | Singapore Exchange Securities Trading Limited |
Subject: | Changes in Composition of the Board Committees |
We, Thai Beverage Public Company Limited (the "Company"), refer to the resolutions of the Board of Directors Meeting No. 1/2021-2022 held on 26 November 2021, and our announcements that were separately released today in relation to the cessation of Mr. Prasit Kovilaikool as a director of the Company ("Director") and the appointment of Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D. as an independent non-executive director of the Company, with immediate effect.
Further to the above-mentioned cessation of directorship of Mr. Prasit Kovilaikool and appointment of Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D. as a new independent non-executive Director, the Company would like to announce that the Board of Directors ("Board") has considered and approved changes in the composition of the Board Committees of the Company, and the Board Committees will be reconstituted with effect from 26 November 2021 as follows:
1. Audit Committee
Ms. Potjanee Thanavaranit has been appointed as the Chairman of the Audit Committee and Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D. has been appointed as a member of the Audit Committee and is considered by the Board to be independent for the purposes of Rule 704(8) of the Listing Manual. Accordingly, the composition of the Audit Committee is as follows:
- Ms. Potjanee Thanavaranit (Chairman)
- Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D.
- Mr. Timothy Chia Chee Ming*
- Prof. Khemchai Chutiwongse
- Mr. Timothy Chia Chee Ming continues to serve as the Lead Independent Director for reviewing Interested Person Transactions undertaken by the ThaiBev Group ("Lead Independent Director for IPTs"). The Board appoints a Lead Independent Director for IPTs to lead the Audit Committee in its role in respect of Interested Person Transactions undertaken by the ThaiBev Group.
2. Nomination Committee
Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D. has been appointed as the Chairman of the Nomination Committee and Ms. Potjanee Thanavaranit has been appointed a member of the Nomination Committee. Accordingly, the composition of the Nomination Committee is as follows:
- Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D. (Chairman)
- Khunying Wanna Sirivadhanabhakdi
- Ms. Potjanee Thanavaranit
- Dr. Chatri Banchuin
- Remuneration Committee
Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D. has been appointed as the Chairman of the Remuneration Committee. Accordingly, the composition of the Remuneration Committee is as follows: - Clinical Prof. Emeritus Piyasakol Sakolsatayadorn, M.D. (Chairman)
- Dr. Chatri Banchuin
- Prof. Khemchai Chutiwongse
-
Sustainability and Risk Management Committee
Ms. Potjanee Thanavaranit has been appointed as the Chairman of the Sustainability and Risk Management Committee. Accordingly, the composition of the Sustainability and Risk Management Committee is as follows: - Ms. Potjanee Thanavaranit (Chairman)
- Mr. Thapana Sirivadhanabhakdi
- Mr. Ueychai Tantha-Obhas
- Mr. Sithichai Chaikriangkrai
- Dr. Pisanu Vichiensanth
- Mr. Prapakon Thongtheppairot
- Mr. Kosit Suksingha
- Mr. Edmond Neo Kim Soon
- Dr. Agapol Na Songkhla
- Ms. Nongnuch Buranasetkul
- Mr. Jean Lebreton
- Mr. Pramote Hassamontr
- Mr. Banjong Chintanasiri
- Ms. Nantika Ninvoraskul
- Mr. Pravit Sukhum
- Ms. Tongjai Thanachanan
-
Lead Independent Director
Ms. Potjanee Thanavaranit has been appointed as the Lead Independent Director of the Company.
Please be informed accordingly.
Yours faithfully,
Nantika Ninvoraskul
Company Secretary
THBEV- Changes in Composition of the Board Committees | -2- |
26 November 2021 |

